Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain.

Lamers SL, Salemi M, Galligan DC, Morris A, Gray R, Fogel G, Zhao L, McGrath MS.

J Neurovirol. 2010 May;16(3):230-41. doi: 10.3109/13550281003735709.

2.

Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients.

Power C, McArthur JC, Nath A, Wehrly K, Mayne M, Nishio J, Langelier T, Johnson RT, Chesebro B.

J Virol. 1998 Nov;72(11):9045-53.

4.
5.

High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS.

Zhao L, Galligan DC, Lamers SL, Yu S, Shagrun L, Salemi M, McGrath MS.

Sci China C Life Sci. 2009 Jul;52(7):651-6. doi: 10.1007/s11427-009-0085-5. Epub 2009 Jul 30.

PMID:
19641870
6.

Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-Hodgkins lymphoma.

Salemi M, Lamers SL, Huysentruyt LC, Galligan D, Gray RR, Morris A, McGrath MS.

PLoS One. 2009 Dec 3;4(12):e8153. doi: 10.1371/journal.pone.0008153.

7.

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia.

Glass JD, Fedor H, Wesselingh SL, McArthur JC.

Ann Neurol. 1995 Nov;38(5):755-62.

PMID:
7486867
8.

A simian human immunodeficiency virus with a nonfunctional Vpu (deltavpuSHIV(KU-1bMC33)) isolated from a macaque with neuroAIDS has selected for mutations in env and nef that contributed to its pathogenic phenotype.

Singh DK, McCormick C, Pacyniak E, Lawrence K, Dalton SB, Pinson DM, Sun F, Berman NE, Calvert M, Gunderson RS, Wong SW, Stephens EB.

Virology. 2001 Mar 30;282(1):123-40.

10.
12.

Human immunodeficiency virus type 1 clade A and D neurotropism: molecular evolution, recombination, and coreceptor use.

Zhang K, Hawken M, Rana F, Welte FJ, Gartner S, Goldsmith MA, Power C.

Virology. 2001 Apr 25;283(1):19-30.

13.
14.

Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.

Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B.

J Neurovirol. 2010 Feb;16(1):25-32. doi: 10.3109/13550280903552420.

15.

HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype.

Cunningham AL, Naif H, Saksena N, Lynch G, Chang J, Li S, Jozwiak R, Alali M, Wang B, Fear W, Sloane A, Pemberton L, Brew B.

J Leukoc Biol. 1997 Jul;62(1):117-25.

PMID:
9226002
16.

Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy.

Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald S, Jernigan T, Masliah E; HNRC Group.

AIDS. 2002 May 3;16(7):1019-29.

17.

Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.

Thomas ER, Dunfee RL, Stanton J, Bogdan D, Taylor J, Kunstman K, Bell JE, Wolinsky SM, Gabuzda D.

Virology. 2007 Mar 30;360(1):105-19. Epub 2006 Nov 7.

18.
19.

Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes.

Olivieri KC, Agopian KA, Mukerji J, Gabuzda D.

AIDS Res Hum Retroviruses. 2010 Apr;26(4):495-500. doi: 10.1089/aid.2009.0257.

20.

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, G√ľnthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK.

J Virol. 2005 Feb;79(3):1772-88.

Supplemental Content

Support Center